HB0017 not checked
Huahai Pharmaceutical (Huaota)
FollowEvery change as it happens, and a Monday email
Trials
1 active
6 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Psoriasis, Ankylosing Spondylitis
- Main trialPhase 1
- “The goal of this clinical trial is to (PART 1) to evaluate the safety and tolerability of a single subcutaneous injection of HB0017 Injection in healthy subjects with low body weight; ( PART 2) to compare the pharmacokinetics (PK) of HB0017 following single subcutaneous administration at different injection sites at the same dose.”In the company’s words, NCT07920861 on ClinicalTrials.gov
Other drugs for Psoriasis
- ZasocitinibTakeda · Phase 3
- TQH3906Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Phase 3
- BimekizumabUCB Biopharma SRL · Phase 3
- PiclidenosonCan-Fite BioPharma · Phase 3
- Total coumarin creamPsoriasis Research Institute of Guangzhou · Phase 3
- RisankizumabAbbVie · Phase 3
Coming up1
- 31 DecPhase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 31 Dec 2026 | A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight Subjects; and Pharmacokinetics at Different Subcutaneous Injection Sites at the Same Dose | |
| Phase 3Completed | 15 Nov 2024 | Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis | |
| Phase 2Completed | 23 May 2023 | A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis | |
| Phase 2Completed | 30 Apr 2025 | A Phase 2 Study of HB0017 in Psoriasis Patients | |
| Phase 1Completed | 2 Jan 2021 | A Study of Injection HB0017 in Adult Healthy Volunteers | |
| Phase 1Completed | 31 May 2022 | A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026